» Articles » PMID: 2546162

Synthesis and Characterization of a Series of Diarylguanidines That Are Noncompetitive N-methyl-D-aspartate Receptor Antagonists with Neuroprotective Properties

Overview
Specialty Science
Date 1989 Jul 1
PMID 2546162
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Four diarylguanidine derivatives were synthesized. These compounds were found to displace, at submicromolar concentrations, 3H-labeled 1-[1-(2-thienyl)cyclohexyl]piperidine and (+)-[3H]MK-801 from phencyclidine receptors in brain membrane preparations. In electrophysiological experiments the diarylguanidines blocked N-methyl-D-aspartate (NMDA)-activated ion channels. These diarylguanidines also protected rat hippocampal neurons in vitro from glutamate-induced cell death. Our results show that some diarylguanidines are noncompetitive antagonists of NMDA receptor-mediated responses and have the neuroprotective property that is commonly associated with blockers of the NMDA receptor-gated cation channel. Diarylguanidines are structurally unrelated to known blockers of NMDA channels and, therefore, represent a new compound series for the development of neuroprotective agents with therapeutic value in patients suffering from stroke, from brain or spinal cord trauma, from hypoglycemia, and possibly from brain ischemia due to heart attack.

Citing Articles

Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury.

Lai K, Pritisanac I, Liu Z, Liu H, Gong L, Li M Nature. 2024; 631(8022):826-834.

PMID: 38987597 PMC: 11269185. DOI: 10.1038/s41586-024-07684-7.


Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using studies.

Sharma M, Mittal A, Singh A, Jainarayanan A, Sharma S, Paliwal S Biol Methods Protoc. 2020; 5(1):bpaa013.

PMID: 32913897 PMC: 7474860. DOI: 10.1093/biomethods/bpaa013.


Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function.

MacDougall G, Anderton R, Trimble A, Mastaglia F, Knuckey N, Meloni B Molecules. 2020; 25(13).

PMID: 32610439 PMC: 7412265. DOI: 10.3390/molecules25132977.


Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action.

Meloni B, Mastaglia F, Knuckey N Front Neurol. 2020; 11:108.

PMID: 32158425 PMC: 7052017. DOI: 10.3389/fneur.2020.00108.


In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.

MacDougall G, Anderton R, Ouliel E, Gao J, Redmond S, Knuckey N Mol Cell Biochem. 2019; 464(1-2):27-38.

PMID: 31679100 DOI: 10.1007/s11010-019-03646-0.


References
1.
Zukin S, Zukin R . Specific [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci U S A. 1979; 76(10):5372-6. PMC: 413145. DOI: 10.1073/pnas.76.10.5372. View

2.
McBurney R, Neering I . The measurement of changes in intracellular free calcium during action potentials in mammalian neurones. J Neurosci Methods. 1985; 13(1):65-76. DOI: 10.1016/0165-0270(85)90044-5. View

3.
Honore T, Drejer J, Nielsen M . Calcium discriminates two [3H]kainate binding sites with different molecular target sizes in rat cortex. Neurosci Lett. 1986; 65(1):47-52. DOI: 10.1016/0304-3940(86)90118-7. View

4.
Wong E, Kemp J, Priestley T, Knight A, Woodruff G, Iversen L . The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986; 83(18):7104-8. PMC: 386661. DOI: 10.1073/pnas.83.18.7104. View

5.
Bristow D, Bowery N, Woodruff G . Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain. Eur J Pharmacol. 1986; 126(3):303-7. DOI: 10.1016/0014-2999(86)90062-2. View